Quality | 2018.10.18
Predicine Establishes Dual CAP Accreditation for its Genomic Sequencing Laboratories in US and China to Support Global Clinical Trials
Predicine has established a unified global quality management system through its CAP/CLIA facility in the San Francisco Bay Area and CAP facility in Shanghai, China to offer cross-border harmonized biomarker assays for global clinical trials.
(PRWeb October 18, 2018)
Read the full story at https://www.prweb.com/releases/predicine_establishes_dual_cap_accreditation_for_its_genomic_sequencing_laboratories_in_us_and_china_to_support_global_clinical_trials/prweb15850777.htm
For more information, please visit
https://www.prweb.com/releases/predicine[...]nical_trials/prweb15850777.htm
